Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Key Takeaways of the Global Tirzepatide Market Type 2 diabetes holds the largest market share by indication, accounting for an expected in 2026, due to the growing global prevalence of type 2 diabetes
Furthermore, weight reduction results were mostly in line with a previous ITC between tirzepatide and semaglutide, which demonstrated greater weight reduction for tirzepatide 10 and 15 mg versus semaglutide 2.4 mg [23]
Liraglutide (Victoza, Saxenda) What it is: Liraglutide, sold under the brand names Victoza for diabetes and Saxenda for weight loss, has been on the market longer than semaglutide
SGLT2i increased serum magnesium levels and reduced uric acid levels
US$ 28.36
US$ 24.32
US$ 25.99
US$ 21.80
US$ 23.43
US$ 28.09
